Related Experiment Video
Updated: Jul 19, 2025

09:51
Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
Published on: May 25, 2018
34.1K
The Object-Based and Process-Based Regulation of Genome Editing
Michal Koščík1,2, Eliška Vladíková1
1Department of Public Health, Faculty of Medicine, Masaryk University Kamenice 753/5, 625 00 Brno Czech Republic.
European Journal of Health Law
|August 15, 2023
Summary
The EU regulatory framework can address germline editing safety and efficacy. However, assessing moral and societal impacts of this advanced technology requires national-level evaluation by EU member states.
Area of Science:
- Biotechnology Law
- Genomic Medicine
- European Union Policy
Background:
- Rapid scientific advancements, particularly in germline editing technologies, challenge existing regulatory frameworks.
- The European Union (EU) regulatory landscape for these technologies is fragmented, comprising international law, secondary EU law, and national legislation.
- Current regulations are heavily influenced by the precautionary principle due to uncertainties regarding the impact of genome editing.
Purpose of the Study:
- To evaluate the adequacy of the EU's regulatory framework in addressing germline editing technologies.
- To determine if existing EU legal tools can manage the implications of scientific progress in gene editing.
- To differentiate between the EU's capacity to regulate technical aspects versus ethical considerations of germline editing.
Main Methods:
- Analysis of the existing EU regulatory framework for advanced treatments and medicinal products.
- Comparative review of international law, secondary EU law, and national legislation within EU member states.
- Assessment of the influence of the precautionary principle on current regulations.
Main Results:
- The EU framework possesses the fundamental capacity to address the safety and efficacy of germline editing technologies.
- The precautionary principle's relevance diminishes as scientific knowledge expands, necessitating a shift towards knowledge-based regulation.
- Existing EU regulations are insufficient for evaluating the moral and societal consequences of germline editing.
Conclusions:
- The EU's regulatory structure is capable of managing the technical aspects of germline editing, focusing on safety and efficacy.
- The assessment of ethical, moral, and societal impacts of germline editing technologies should be handled at the national level by individual EU member states.
- A nuanced regulatory approach is needed, distinguishing between technical validation and broader societal implications.
Related Concept Videos
What is Genetic Engineering?
74.4K
Overview
74.4K
CRISPR
52.3K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.3K
CRISPR/Cas9 Genome Editing
59
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
59
Regulation of Expression Occurs at Multiple Steps
22.8K
Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
22.8K
CRISPR and crRNAs
17.1K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.1K
Epigenetic Regulation
3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.1K

